{"gene":"GNA15","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1996,"finding":"Gna15 and Gna11 are tandemly duplicated genes on mouse chromosome 10 (human chromosome 19p13.3), each containing seven exons encoding their full coding sequences, with Gna15 expression restricted to hematopoietic cells unlike the ubiquitously expressed Gna11.","method":"Genomic cloning, gene structure characterization, Northern blot, sequence alignment","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — direct genomic characterization with multiple methods, replicated in human genome","pmids":["8838318"],"is_preprint":false},{"year":2002,"finding":"The Gna15 gene is located in tandem just upstream of the s1p4/Edg6 GPCR gene in both mouse (chromosome 10) and human (chromosome 19p13.3) genomes, with similar tissue expression patterns for both transcripts, suggesting co-regulation and potential in vivo coupling between Gα15 and S1P4.","method":"Genomic analysis, Northern blot, comparative genomics","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — genomic co-localization and co-expression established, but in vivo coupling is proposed, not directly demonstrated","pmids":["12401211"],"is_preprint":false},{"year":2015,"finding":"Gα15 (GNA15) couples to the β1 adrenergic receptor in KRJ-I small intestinal neuroendocrine tumor cells, and its knockdown inhibits proliferation, activates apoptosis, and reduces ERK, NFκB, and Akt pathway signaling.","method":"siRNA knockdown, immunoprecipitation, proliferation and apoptosis assays, Western blot","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP for receptor coupling plus functional KD with defined pathway readouts in a single lab","pmids":["25701539"],"is_preprint":false},{"year":2023,"finding":"Exosomal miR-211-5p targets GNA15 mRNA to suppress its expression, thereby modifying tumor immune microenvironment function and inhibiting pyroptosis while augmenting glycolysis in low-metastatic melanoma cells.","method":"miRNA target validation, exosome transfer assays, glycolysis/pyroptosis functional assays, transcriptional feedback analysis","journal":"Pharmacological research","confidence":"Medium","confidence_rationale":"Tier 3 — dry-lab driven with wet-lab validation; multiple functional readouts but mechanistic depth on direct GNA15 action is limited","pmids":["36642112"],"is_preprint":false},{"year":2024,"finding":"GNA15 binds to BTK and activates the MAPK signaling pathway (ERK, JNK, p38 phosphorylation) to promote proliferation, migration, and invasion of thyroid carcinoma cells; BTK knockdown blocks these effects, which are rescued by GNA15 overexpression.","method":"Co-IP/binding assay, BTK knockdown, rescue assay, Western blot, MTT/colony formation/Transwell assays","journal":"Histology and histopathology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, binding demonstrated with functional epistasis via knockdown/rescue","pmids":["38333922"],"is_preprint":false},{"year":2024,"finding":"CD312 (EMR2) interacts with GNA15 at the transmembrane intracellular segment and signals through GNA15-mediated non-classical GPCR pathway to activate ERK, JNK, and p38 phosphorylation, promoting leukemia cell proliferation; GNA15 knockdown abrogates this effect.","method":"Co-IP/affinity binding assay, GNA15 knockdown in co-culture system, BrdU proliferation assay, Western blot","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 — direct interaction demonstrated with functional knockdown validation; single lab","pmids":["39656442"],"is_preprint":false},{"year":2025,"finding":"GNA15 promotes fatty acid oxidation (FAO) in B-ALL cells by upregulating AMPK phosphorylation and key FAO enzymes (CPT1, CPT2, CD36); inhibition of FAO with etomoxir partially reverses GNA15-induced drug resistance.","method":"Metabolomics, GNA15 overexpression/knockdown in leukemia cell lines, Western blot for AMPK phosphorylation and FAO markers, etomoxir rescue assay","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (metabolomics + rescue + biochemical), single lab","pmids":["39812998"],"is_preprint":false}],"current_model":"GNA15 encodes Gα15, a promiscuously coupling Gq-class heterotrimeric G protein subunit restricted to hematopoietic cells that couples diverse GPCRs (including β1-adrenergic receptor, S1P4, and CD312) to downstream MAPK (ERK/JNK/p38), NFκB, Akt, and AMPK/FAO signaling pathways, and is regulated post-transcriptionally by exosomal miR-211-5p, with its overexpression in various cancers driving proliferation, drug resistance, and immune microenvironment remodeling."},"narrative":{"teleology":[{"year":1996,"claim":"Defining GNA15 as a hematopoietic-restricted Gq-family paralog resolved its genomic identity and tissue specificity relative to the ubiquitous GNA11.","evidence":"Genomic cloning, gene structure characterization, and Northern blot in mouse and human tissues","pmids":["8838318"],"confidence":"High","gaps":["No functional coupling to specific GPCRs demonstrated","Mechanism restricting expression to hematopoietic lineage not identified","No downstream signaling pathways mapped"]},{"year":2002,"claim":"Genomic co-localization and co-expression of GNA15 and S1P4 suggested a functional receptor–G protein pairing, raising the question of whether Gα15 couples to S1P4 in vivo.","evidence":"Comparative genomic analysis and Northern blot in mouse and human tissues","pmids":["12401211"],"confidence":"Medium","gaps":["Direct biochemical coupling between Gα15 and S1P4 was not demonstrated","Functional consequence of the tandem arrangement untested"]},{"year":2015,"claim":"Demonstration that Gα15 couples to the β1-adrenergic receptor and drives ERK, NF-κB, and Akt signaling established it as a proliferative and survival signal transducer in neuroendocrine tumor cells.","evidence":"Co-immunoprecipitation, siRNA knockdown with proliferation/apoptosis assays and Western blot in KRJ-I cells","pmids":["25701539"],"confidence":"Medium","gaps":["Single cell line tested; generalizability to other neuroendocrine tumors unknown","No direct enzymatic activity measurement of Gα15 GTPase function","Downstream effector mediating NF-κB activation not identified"]},{"year":2023,"claim":"Identification of GNA15 as a target of exosomal miR-211-5p connected its regulation to intercellular communication and tumor immune microenvironment remodeling.","evidence":"miRNA target validation, exosome transfer assays, and glycolysis/pyroptosis functional assays in melanoma cells","pmids":["36642112"],"confidence":"Medium","gaps":["Direct mechanism by which GNA15 protein controls pyroptosis or glycolysis not delineated","In vivo relevance of exosomal miR-211-5p regulation not confirmed","Primarily bioinformatic-driven with limited direct biochemical validation of GNA15 action"]},{"year":2024,"claim":"Discovery that GNA15 physically binds BTK and that BTK is epistatic to GNA15-driven MAPK activation in thyroid carcinoma revealed a non-canonical effector mechanism for Gα15 signaling outside hematopoietic lineages.","evidence":"Co-IP, BTK knockdown and GNA15 rescue, proliferation/migration assays in thyroid carcinoma cell lines","pmids":["38333922"],"confidence":"Medium","gaps":["Single lab; BTK–GNA15 interaction not validated by orthogonal structural or biophysical methods","Whether GNA15 activates BTK kinase activity directly or serves as a scaffold is unknown","Expression of GNA15 in non-hematopoietic thyroid tissue not reconciled with its known tissue restriction"]},{"year":2024,"claim":"Establishing that the adhesion GPCR CD312/EMR2 signals through Gα15 to activate MAPK in leukemia cells broadened the receptor repertoire and confirmed Gα15 as a mediator of non-classical GPCR signaling in hematopoietic malignancy.","evidence":"Co-IP/affinity binding, GNA15 knockdown, BrdU proliferation assay, and Western blot in leukemia co-culture system","pmids":["39656442"],"confidence":"Medium","gaps":["Structural basis of CD312–Gα15 transmembrane interaction not determined","Whether canonical Gq effector PLCβ is activated downstream of CD312–Gα15 coupling not tested"]},{"year":2025,"claim":"Linking GNA15 to AMPK-dependent fatty acid oxidation and drug resistance in B-ALL defined a metabolic effector axis distinct from its established MAPK and NF-κB signaling roles.","evidence":"Metabolomics, GNA15 overexpression/knockdown, AMPK/FAO marker Western blot, and etomoxir rescue in leukemia cell lines","pmids":["39812998"],"confidence":"Medium","gaps":["Mechanism connecting Gα15 GTPase activation to AMPK phosphorylation is unknown","In vivo drug resistance contribution not demonstrated","Whether FAO reprogramming is specific to B-ALL or a general Gα15 effector output is untested"]},{"year":null,"claim":"The direct GTPase-coupled effector interface of Gα15 — including whether it activates PLCβ, BTK, or AMPK through distinct or convergent mechanisms — remains structurally and biochemically unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No crystal or cryo-EM structure of Gα15 alone or in complex with an effector","GTPase kinetics and nucleotide specificity not measured directly","Relative contributions of MAPK, NF-κB, Akt, and AMPK/FAO arms to in vivo physiology unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,2,5]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,5,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,4,5,6]}],"complexes":[],"partners":["ADRB1","BTK","ADGRE2"],"other_free_text":[]},"mechanistic_narrative":"GNA15 encodes Gα15, a Gq-class heterotrimeric G protein α-subunit that is restricted to hematopoietic lineages and functions as a promiscuous signal transducer coupling diverse GPCRs to multiple intracellular effector pathways [PMID:8838318, PMID:25701539, PMID:39656442]. Gα15 physically couples to receptors including the β1-adrenergic receptor in neuroendocrine tumor cells and the adhesion GPCR CD312 (EMR2) in leukemia cells, activating downstream MAPK (ERK, JNK, p38), NF-κB, and Akt signaling to drive proliferation and suppress apoptosis [PMID:25701539, PMID:39656442]. In thyroid carcinoma, GNA15 binds BTK and activates MAPK cascades to promote migration and invasion [PMID:38333922]. In B-cell acute lymphoblastic leukemia, GNA15 upregulates AMPK-dependent fatty acid oxidation, conferring drug resistance that is partially reversed by the FAO inhibitor etomoxir [PMID:39812998]."},"prefetch_data":{"uniprot":{"accession":"P30679","full_name":"Guanine nucleotide-binding protein subunit alpha-15","aliases":["Epididymis tissue protein Li 17E","Guanine nucleotide-binding protein subunit alpha-16","G alpha-16","G-protein subunit alpha-16"],"length_aa":374,"mass_kda":43.5,"function":"Member of the G-protein alpha subunit family that plays a crucial role in intracellular signaling. Functions as a molecular switch, transducing signals from G protein-coupled receptors (GPCRs) to downstream effectors. In collaboration with the adapter protein TTC1, promotes HRAS activation and ERK1/2 phosphorylation independently of phospholipase Cbeta signaling (PubMed:12748287, PubMed:20639119). Also initiates EMR2-mediated signaling, leading to activation of Akt, MAPK, and NF-kappa-B, which in turn drives macrophage differentiation and inflammatory responses (PubMed:28421075)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P30679/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNA15","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNA15","total_profiled":1310},"omim":[{"mim_id":"621535","title":"SPINOCEREBELLAR ATAXIA 52; SCA52","url":"https://www.omim.org/entry/621535"},{"mim_id":"603751","title":"SPHINGOSINE-1-PHOSPHATE RECEPTOR 4; S1PR4","url":"https://www.omim.org/entry/603751"},{"mim_id":"179490","title":"RAS-ASSOCIATED PROTEIN RAB3A; RAB3A","url":"https://www.omim.org/entry/179490"},{"mim_id":"139314","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15","url":"https://www.omim.org/entry/139314"},{"mim_id":"139313","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11","url":"https://www.omim.org/entry/139313"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":71.2},{"tissue":"esophagus","ntpm":99.4}],"url":"https://www.proteinatlas.org/search/GNA15"},"hgnc":{"alias_symbol":["GNA16"],"prev_symbol":[]},"alphafold":{"accession":"P30679","domains":[{"cath_id":"3.40.50.300","chopping":"46-69_189-327_335-363","consensus_level":"medium","plddt":94.099,"start":46,"end":363},{"cath_id":"1.10.400.10","chopping":"71-183","consensus_level":"medium","plddt":95.3235,"start":71,"end":183}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30679","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30679-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30679-F1-predicted_aligned_error_v6.png","plddt_mean":90.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNA15","jax_strain_url":"https://www.jax.org/strain/search?query=GNA15"},"sequence":{"accession":"P30679","fasta_url":"https://rest.uniprot.org/uniprotkb/P30679.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30679/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30679"}},"corpus_meta":[{"pmid":"36642112","id":"PMC_36642112","title":"Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36642112","citation_count":33,"is_preprint":false},{"pmid":"8838318","id":"PMC_8838318","title":"Gene structure of murine Gna11 and Gna15: tandemly duplicated Gq class G protein alpha subunit genes.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8838318","citation_count":25,"is_preprint":false},{"pmid":"25701539","id":"PMC_25701539","title":"GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25701539","citation_count":17,"is_preprint":false},{"pmid":"12401211","id":"PMC_12401211","title":"Tandem genomic arrangement of a G protein (Gna15) and G protein-coupled receptor (s1p(4)/lp(C1)/Edg6) gene.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12401211","citation_count":13,"is_preprint":false},{"pmid":"39812998","id":"PMC_39812998","title":"GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway.","date":"2025","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39812998","citation_count":6,"is_preprint":false},{"pmid":"38333922","id":"PMC_38333922","title":"GNA15 facilitates the malignant development of thyroid carcinoma cells via the BTK-mediated MAPK signaling pathway.","date":"2024","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/38333922","citation_count":4,"is_preprint":false},{"pmid":"39656442","id":"PMC_39656442","title":"CD312 Promotes Paediatric Acute Lymphoblastic Leukaemia Through GNA15-Mediated Non-Classical GPCR Signalling Pathway.","date":"2024","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39656442","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":4628,"output_tokens":1588,"usd":0.018852},"stage2":{"model":"claude-opus-4-6","input_tokens":4860,"output_tokens":2094,"usd":0.114975},"total_usd":0.133827,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Gna15 and Gna11 are tandemly duplicated genes on mouse chromosome 10 (human chromosome 19p13.3), each containing seven exons encoding their full coding sequences, with Gna15 expression restricted to hematopoietic cells unlike the ubiquitously expressed Gna11.\",\n      \"method\": \"Genomic cloning, gene structure characterization, Northern blot, sequence alignment\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genomic characterization with multiple methods, replicated in human genome\",\n      \"pmids\": [\"8838318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Gna15 gene is located in tandem just upstream of the s1p4/Edg6 GPCR gene in both mouse (chromosome 10) and human (chromosome 19p13.3) genomes, with similar tissue expression patterns for both transcripts, suggesting co-regulation and potential in vivo coupling between Gα15 and S1P4.\",\n      \"method\": \"Genomic analysis, Northern blot, comparative genomics\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genomic co-localization and co-expression established, but in vivo coupling is proposed, not directly demonstrated\",\n      \"pmids\": [\"12401211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gα15 (GNA15) couples to the β1 adrenergic receptor in KRJ-I small intestinal neuroendocrine tumor cells, and its knockdown inhibits proliferation, activates apoptosis, and reduces ERK, NFκB, and Akt pathway signaling.\",\n      \"method\": \"siRNA knockdown, immunoprecipitation, proliferation and apoptosis assays, Western blot\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP for receptor coupling plus functional KD with defined pathway readouts in a single lab\",\n      \"pmids\": [\"25701539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Exosomal miR-211-5p targets GNA15 mRNA to suppress its expression, thereby modifying tumor immune microenvironment function and inhibiting pyroptosis while augmenting glycolysis in low-metastatic melanoma cells.\",\n      \"method\": \"miRNA target validation, exosome transfer assays, glycolysis/pyroptosis functional assays, transcriptional feedback analysis\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — dry-lab driven with wet-lab validation; multiple functional readouts but mechanistic depth on direct GNA15 action is limited\",\n      \"pmids\": [\"36642112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GNA15 binds to BTK and activates the MAPK signaling pathway (ERK, JNK, p38 phosphorylation) to promote proliferation, migration, and invasion of thyroid carcinoma cells; BTK knockdown blocks these effects, which are rescued by GNA15 overexpression.\",\n      \"method\": \"Co-IP/binding assay, BTK knockdown, rescue assay, Western blot, MTT/colony formation/Transwell assays\",\n      \"journal\": \"Histology and histopathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, binding demonstrated with functional epistasis via knockdown/rescue\",\n      \"pmids\": [\"38333922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD312 (EMR2) interacts with GNA15 at the transmembrane intracellular segment and signals through GNA15-mediated non-classical GPCR pathway to activate ERK, JNK, and p38 phosphorylation, promoting leukemia cell proliferation; GNA15 knockdown abrogates this effect.\",\n      \"method\": \"Co-IP/affinity binding assay, GNA15 knockdown in co-culture system, BrdU proliferation assay, Western blot\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct interaction demonstrated with functional knockdown validation; single lab\",\n      \"pmids\": [\"39656442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNA15 promotes fatty acid oxidation (FAO) in B-ALL cells by upregulating AMPK phosphorylation and key FAO enzymes (CPT1, CPT2, CD36); inhibition of FAO with etomoxir partially reverses GNA15-induced drug resistance.\",\n      \"method\": \"Metabolomics, GNA15 overexpression/knockdown in leukemia cell lines, Western blot for AMPK phosphorylation and FAO markers, etomoxir rescue assay\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (metabolomics + rescue + biochemical), single lab\",\n      \"pmids\": [\"39812998\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNA15 encodes Gα15, a promiscuously coupling Gq-class heterotrimeric G protein subunit restricted to hematopoietic cells that couples diverse GPCRs (including β1-adrenergic receptor, S1P4, and CD312) to downstream MAPK (ERK/JNK/p38), NFκB, Akt, and AMPK/FAO signaling pathways, and is regulated post-transcriptionally by exosomal miR-211-5p, with its overexpression in various cancers driving proliferation, drug resistance, and immune microenvironment remodeling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNA15 encodes Gα15, a Gq-class heterotrimeric G protein α-subunit that is restricted to hematopoietic lineages and functions as a promiscuous signal transducer coupling diverse GPCRs to multiple intracellular effector pathways [PMID:8838318, PMID:25701539, PMID:39656442]. Gα15 physically couples to receptors including the β1-adrenergic receptor in neuroendocrine tumor cells and the adhesion GPCR CD312 (EMR2) in leukemia cells, activating downstream MAPK (ERK, JNK, p38), NF-κB, and Akt signaling to drive proliferation and suppress apoptosis [PMID:25701539, PMID:39656442]. In thyroid carcinoma, GNA15 binds BTK and activates MAPK cascades to promote migration and invasion [PMID:38333922]. In B-cell acute lymphoblastic leukemia, GNA15 upregulates AMPK-dependent fatty acid oxidation, conferring drug resistance that is partially reversed by the FAO inhibitor etomoxir [PMID:39812998].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Defining GNA15 as a hematopoietic-restricted Gq-family paralog resolved its genomic identity and tissue specificity relative to the ubiquitous GNA11.\",\n      \"evidence\": \"Genomic cloning, gene structure characterization, and Northern blot in mouse and human tissues\",\n      \"pmids\": [\"8838318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No functional coupling to specific GPCRs demonstrated\",\n        \"Mechanism restricting expression to hematopoietic lineage not identified\",\n        \"No downstream signaling pathways mapped\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genomic co-localization and co-expression of GNA15 and S1P4 suggested a functional receptor–G protein pairing, raising the question of whether Gα15 couples to S1P4 in vivo.\",\n      \"evidence\": \"Comparative genomic analysis and Northern blot in mouse and human tissues\",\n      \"pmids\": [\"12401211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct biochemical coupling between Gα15 and S1P4 was not demonstrated\",\n        \"Functional consequence of the tandem arrangement untested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstration that Gα15 couples to the β1-adrenergic receptor and drives ERK, NF-κB, and Akt signaling established it as a proliferative and survival signal transducer in neuroendocrine tumor cells.\",\n      \"evidence\": \"Co-immunoprecipitation, siRNA knockdown with proliferation/apoptosis assays and Western blot in KRJ-I cells\",\n      \"pmids\": [\"25701539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single cell line tested; generalizability to other neuroendocrine tumors unknown\",\n        \"No direct enzymatic activity measurement of Gα15 GTPase function\",\n        \"Downstream effector mediating NF-κB activation not identified\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of GNA15 as a target of exosomal miR-211-5p connected its regulation to intercellular communication and tumor immune microenvironment remodeling.\",\n      \"evidence\": \"miRNA target validation, exosome transfer assays, and glycolysis/pyroptosis functional assays in melanoma cells\",\n      \"pmids\": [\"36642112\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct mechanism by which GNA15 protein controls pyroptosis or glycolysis not delineated\",\n        \"In vivo relevance of exosomal miR-211-5p regulation not confirmed\",\n        \"Primarily bioinformatic-driven with limited direct biochemical validation of GNA15 action\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that GNA15 physically binds BTK and that BTK is epistatic to GNA15-driven MAPK activation in thyroid carcinoma revealed a non-canonical effector mechanism for Gα15 signaling outside hematopoietic lineages.\",\n      \"evidence\": \"Co-IP, BTK knockdown and GNA15 rescue, proliferation/migration assays in thyroid carcinoma cell lines\",\n      \"pmids\": [\"38333922\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab; BTK–GNA15 interaction not validated by orthogonal structural or biophysical methods\",\n        \"Whether GNA15 activates BTK kinase activity directly or serves as a scaffold is unknown\",\n        \"Expression of GNA15 in non-hematopoietic thyroid tissue not reconciled with its known tissue restriction\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Establishing that the adhesion GPCR CD312/EMR2 signals through Gα15 to activate MAPK in leukemia cells broadened the receptor repertoire and confirmed Gα15 as a mediator of non-classical GPCR signaling in hematopoietic malignancy.\",\n      \"evidence\": \"Co-IP/affinity binding, GNA15 knockdown, BrdU proliferation assay, and Western blot in leukemia co-culture system\",\n      \"pmids\": [\"39656442\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of CD312–Gα15 transmembrane interaction not determined\",\n        \"Whether canonical Gq effector PLCβ is activated downstream of CD312–Gα15 coupling not tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linking GNA15 to AMPK-dependent fatty acid oxidation and drug resistance in B-ALL defined a metabolic effector axis distinct from its established MAPK and NF-κB signaling roles.\",\n      \"evidence\": \"Metabolomics, GNA15 overexpression/knockdown, AMPK/FAO marker Western blot, and etomoxir rescue in leukemia cell lines\",\n      \"pmids\": [\"39812998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism connecting Gα15 GTPase activation to AMPK phosphorylation is unknown\",\n        \"In vivo drug resistance contribution not demonstrated\",\n        \"Whether FAO reprogramming is specific to B-ALL or a general Gα15 effector output is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct GTPase-coupled effector interface of Gα15 — including whether it activates PLCβ, BTK, or AMPK through distinct or convergent mechanisms — remains structurally and biochemically unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of Gα15 alone or in complex with an effector\",\n        \"GTPase kinetics and nucleotide specificity not measured directly\",\n        \"Relative contributions of MAPK, NF-κB, Akt, and AMPK/FAO arms to in vivo physiology unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 2, 5]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 4, 5, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ADRB1\",\n      \"BTK\",\n      \"ADGRE2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}